Skip to content

Now providing Mesenchymal cell-based immunomodulation for Covid19-induced hypercytokinemia. Contact us to learn more

Somata
Genesis Biopharmaceuticals
  • Covid-19
    • Clinical Trials
    • Products
      • Ventilator
  • Treatments
    • Neurodegenerative Diseases
      • Multiple sclerosis
      • Amyotrophic lateral sclerosis
      • Parkinson’s disease
      • Cerebral palsy
      • Autism
    • Diabetes T2
    • Critical limb ischemia
    • Kidney disorder
    • Stroke
  • Biopharmaceuticals
    • Neutrojen
    • Somajen
    • Stem cells
  • Services
    • Bioequivalence
    • Pharmacokinetics
  • Discoveries
    • Multiple Sclerosis
    • COVID-19
  • Contact

Day: May 13, 2018

Trump directs USTR to take up pricing of pharmaceuticals, medical devices
Articles

Trump directs USTR to take up pricing of pharmaceuticals, medical devices

President Donald Trump today directed his top trade negotiator to strongly take up with all countries the fixing of prices of American pharmaceuticals and medical devices. Describing such fixing of prices by other countries as…

by admin
- May. 13, 2018
chat_bubble_outline0
Read morearrow_forward
Scientists Have Identified The Physical Source of Anxiety in The Brain
Articles

Scientists Have Identified The Physical Source of Anxiety in The Brain

A recent study investigating the neurological basis of anxiety in the brain has identified ‘anxiety cells’ located in the hippocampus – which not only regulate anxious behaviour but can be controlled by a beam of…

by admin
- May. 13, 2018
chat_bubble_outline0
Read morearrow_forward
https://www.facebook.com/somatagenesis
500 E 10th St., Burley, Idaho 83318, USA
USA Tollfree 1 844 518 9699
International +1 646 583 1660
info@somatagenesis.com
  • Neutrojen
  • Somajen
  • Stem cells
  • Bioequivalence
  • Contact
  • COVID-19
  • Multiple Sclerosis Research
Copyright © 2023 Somata Genesis, Inc. | 500 E 10th St., Burley, Idaho 83318, USA
  • Facebook
  • LinkedIn
  • Twitter